These diseases are rare in the United States. However, in UK myxomatosis virus is devastating for both wild and companion rabbits. Reported by: Zenopa.com "MSD Animal Health has published positive clinical data for a new vaccine therapy for myxomatosis and rabbit haemorrhagic disease.
The subcutaneously-administered Nobivac Myxo-RHD was shown to provide high-quality protection against both of these two viral diseases, with vaccinated rabbits remaining healthy and suffering no adverse effects.
Researchers trialled the drug at MSD Animal Health's Milton Keynes research centre, with an editorial published in the peer-reviewed journal Veterinary Record suggesting that the product represents a major step forward in rabbit healthcare." Read full article at: Animal Health Supplier News